Cargando…

Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study

INTRODUCTION AND BACKGROUND: A significant proportion of patients with intermediate and high risk squamous cell cancer of the oropharynx (OPSCC) continue to relapse locally despite radical chemoradiotherapy (CRT). The toxicity of the current combination of intensified dose per fraction radiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterson, C, Allwood-Spiers, S, McCrea, I, Foster, J, McJury, M, Thomson, M, Sankaralingam, M, Grose, D, James, A, Rizwanullah, M, McLoone, P, Chalmers, A, Duffton, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893522/
https://www.ncbi.nlm.nih.gov/pubmed/29657994
http://dx.doi.org/10.1016/j.ctro.2016.12.003
_version_ 1783313313828962304
author Paterson, C
Allwood-Spiers, S
McCrea, I
Foster, J
McJury, M
Thomson, M
Sankaralingam, M
Grose, D
James, A
Rizwanullah, M
McLoone, P
Chalmers, A
Duffton, A
author_facet Paterson, C
Allwood-Spiers, S
McCrea, I
Foster, J
McJury, M
Thomson, M
Sankaralingam, M
Grose, D
James, A
Rizwanullah, M
McLoone, P
Chalmers, A
Duffton, A
author_sort Paterson, C
collection PubMed
description INTRODUCTION AND BACKGROUND: A significant proportion of patients with intermediate and high risk squamous cell cancer of the oropharynx (OPSCC) continue to relapse locally despite radical chemoradiotherapy (CRT). The toxicity of the current combination of intensified dose per fraction radiotherapy and platinum based chemotherapy limits further uniform intensification. If a predictive biomarker for outcomes from CRT can be identified during treatment then individualised and adaptive treatment strategies may be employed. METHODS/DESIGN: The MeRInO study is a prospective observational imaging study of patients with intermediate and high risk, locally advanced OPSCC receiving radical RT or concurrent CRT Patients undergo diffusion weighted MRI prior to treatment (MRI_1) and during the third week of RT (MRI_2). Apparent diffusion coefficient (ADC) measurements will be made on each scan for previously specified target lesions (primary and lymph nodes) and change in ADC calculated. Patients will be followed up and disease status for each target lesion noted. The primary aim of the MeRInO study is to determine the threshold change in ADC from baseline to week 3 of RT that may identify the sub-group of non-responders during treatment. DISCUSSION: The use of DW-MRI as a predictive biomarker during RT for SCC H&N is in its infancy but studies to date have found that response to treatment may indeed be predicted by comparison of DW-MRI carried out before and during treatment. However, previous studies have included all sub-sites and biological sub-types. Establishing ADC thresholds that predict for local failure is an essential step towards using DW-MRI to improve the therapeutic ratio in treating SCC H&N. This would be done most robustly in a specific H&N sub-site and in sub-types with similar biological behaviour. The MeRInO study will help establish these thresholds in OPSCC.
format Online
Article
Text
id pubmed-5893522
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-58935222018-04-13 Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study Paterson, C Allwood-Spiers, S McCrea, I Foster, J McJury, M Thomson, M Sankaralingam, M Grose, D James, A Rizwanullah, M McLoone, P Chalmers, A Duffton, A Clin Transl Radiat Oncol Article INTRODUCTION AND BACKGROUND: A significant proportion of patients with intermediate and high risk squamous cell cancer of the oropharynx (OPSCC) continue to relapse locally despite radical chemoradiotherapy (CRT). The toxicity of the current combination of intensified dose per fraction radiotherapy and platinum based chemotherapy limits further uniform intensification. If a predictive biomarker for outcomes from CRT can be identified during treatment then individualised and adaptive treatment strategies may be employed. METHODS/DESIGN: The MeRInO study is a prospective observational imaging study of patients with intermediate and high risk, locally advanced OPSCC receiving radical RT or concurrent CRT Patients undergo diffusion weighted MRI prior to treatment (MRI_1) and during the third week of RT (MRI_2). Apparent diffusion coefficient (ADC) measurements will be made on each scan for previously specified target lesions (primary and lymph nodes) and change in ADC calculated. Patients will be followed up and disease status for each target lesion noted. The primary aim of the MeRInO study is to determine the threshold change in ADC from baseline to week 3 of RT that may identify the sub-group of non-responders during treatment. DISCUSSION: The use of DW-MRI as a predictive biomarker during RT for SCC H&N is in its infancy but studies to date have found that response to treatment may indeed be predicted by comparison of DW-MRI carried out before and during treatment. However, previous studies have included all sub-sites and biological sub-types. Establishing ADC thresholds that predict for local failure is an essential step towards using DW-MRI to improve the therapeutic ratio in treating SCC H&N. This would be done most robustly in a specific H&N sub-site and in sub-types with similar biological behaviour. The MeRInO study will help establish these thresholds in OPSCC. Elsevier 2017-01-10 /pmc/articles/PMC5893522/ /pubmed/29657994 http://dx.doi.org/10.1016/j.ctro.2016.12.003 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Paterson, C
Allwood-Spiers, S
McCrea, I
Foster, J
McJury, M
Thomson, M
Sankaralingam, M
Grose, D
James, A
Rizwanullah, M
McLoone, P
Chalmers, A
Duffton, A
Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study
title Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study
title_full Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study
title_fullStr Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study
title_full_unstemmed Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study
title_short Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study
title_sort study of diffusion weighted mri as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: the merino study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893522/
https://www.ncbi.nlm.nih.gov/pubmed/29657994
http://dx.doi.org/10.1016/j.ctro.2016.12.003
work_keys_str_mv AT patersonc studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT allwoodspierss studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT mccreai studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT fosterj studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT mcjurym studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT thomsonm studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT sankaralingamm studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT grosed studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT jamesa studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT rizwanullahm studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT mcloonep studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT chalmersa studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy
AT dufftona studyofdiffusionweightedmriasapredictivebiomarkerofresponseduringradiotherapyforhighandintermediaterisksquamouscellcanceroftheoropharynxthemerinostudy